1-3 of 3
Steven Vonderfecht
Close
Sort by
Journal Articles

Targeting Leukemic Stem Cells in Acute Myeloid Leukemia Using a CpG-Linked Anti-Mir-126 Oligonucleotide

Lucy Y Ghoda, Ebtesam Nafie, Elizabeth Bloom-Saldana, Patrick T. Fueger, Timothy Synold, James Simpson, Piotr Swiderski, Kokilah Muthaiyah, Bin Zhang, Marcin Kortylewski, Steven Vonderfecht, Le Xuan Truong Nguyen, Jianying Zhang, Joycelynne Palmer, Guido Marcucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 10673–10674.
https://doi.org/10.1182/blood-2022-171147
Published: 2022
Journal Articles

Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

Brief Report
Enrico Caserta, Junie Chea, Megan Minnix, Erasmus K. Poku, Domenico Viola, Steven Vonderfecht, Paul Yazaki, Desiree Crow, Jihane Khalife, James F. Sanchez, Joycelynne M. Palmer, Susanta Hui, Nadia Carlesso, Jonathan Keats, Young Kim, Ralf Buettner, Guido Marcucci, Steven Rosen, John Shively, David Colcher, Amrita Krishnan, Flavia Pichiorri
Journal: Blood
Blood (2018) 131 (7): 741–745.
https://doi.org/10.1182/blood-2017-09-807263
Published: 2018
Includes: Multimedia, Supplemental data
Journal Articles

Copper-64-Labeled Daratumumab As a PET Imaging Tracer for Multiple Myeloma: Potential Use for Minimal Residual Disease Detection

Enrico Caserta, PhD, Junie Chea, Megan Minnix, Domenico Viola, BS, Steven Vonderfecht, Jonathan J Keats, PhD, James F Sanchez, David Colcher, John E. Shively, Amrita Krishnan, MD, Flavia Pichiorri, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3083.
https://doi.org/10.1182/blood.V130.Suppl_1.3083.3083
Published: 2017